A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma
Clinical trial NCT05205161 · TERMINATED
Trial details
- NCT number
- NCT05205161
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2023-08-17
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.